Clinical Trial Update: Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2a trial evaluating the safety of HB-adMSCs for rheumatoid arthritis has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences LLC | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-03-22